Study design
A multicenter, open‐label, randomized, controlled clinical trial (OPTIMA‐4) is designed. The study design is shown in Figure Flowchart of OPtimal management of anTIthroMbotic Agents‐4 trial. DES, drug‐eluting stent; PCI, percutaneous coronary intervention; R, randomization.